Application of pimecrolimus
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vitiligo Vulgaris
Conditions
Vitiligo Vulgaris
Trial Timeline
May 1, 2004 → Nov 1, 2004
NCT ID
NCT00372307About Application of pimecrolimus
Application of pimecrolimus is a phase 2 stage product being developed by Novartis for Vitiligo Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT00372307. Target conditions include Vitiligo Vulgaris.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00372307 | Phase 2 | Completed |
Competing Products
20 competing products in Vitiligo Vulgaris